Side Effects

GLP-1 Injection Site Reactions: What's Normal and What's Not

GLP-1 Companion · 6 min read

Administering a weekly subcutaneous injection is a new skill for most GLP-1 users, and injection site reactions are one of the more common early concerns. The good news: the vast majority of reactions are mild, expected, and largely preventable with proper technique. Understanding what is normal — and which signs warrant a call to your provider — allows you to manage this aspect of GLP-1 therapy with confidence.

Normal Injection Site Reactions

Mild local reactions at the injection site affect approximately 5-10% of GLP-1 users, and include:

• Mild redness (erythema): A small, pink to red area around the injection point, typically less than 2 cm in diameter, that fades within a few hours to 24 hours.
• Small bruise: Minor bleeding from a small vessel is common and harmless. Bruises resolve within days.
• Slight swelling or raised wheal: A small bump at the injection site that typically resolves within 30-60 minutes.
• Mild itching: A brief itch in the hour after injection is a normal local inflammatory response.
• Mild tenderness: The injection site may be slightly tender to touch for 12-24 hours.

None of these reactions require intervention beyond monitoring. They are a normal consequence of the medication being deposited in the subcutaneous tissue and the body's minor local immune response.

The Most Important Prevention: Site Rotation

Rotating injection sites is the single most effective strategy for preventing injection site problems. Using the same location repeatedly causes cumulative tissue trauma and can lead to lipohypertrophy — a hardened, fatty nodule under the skin that alters drug absorption and makes injections more uncomfortable.

Approved Injection Sites

• Abdomen: The area 2 inches around the navel in all directions, and extending out to the flanks. Avoid the navel itself and the bony central midline.
• Outer thighs: The middle third of the outer thigh (lateral aspect), avoiding the inner thigh and the knee and hip joints.
• Upper outer arms: The fleshy back-of-arm area, typically requiring assistance or good flexibility to self-inject.

Rotation Strategy

A systematic rotation pattern prevents overuse of any single area. One approach: divide the abdomen into quadrants and rotate through them over successive weeks (right upper, left upper, left lower, right lower), then cycle through thighs and arms. Move at least an inch from the previous week's site within the same region. Keep a simple log or phone note tracking where you injected each week.

Technique Tips That Reduce Reactions

• Allow the pen to reach room temperature before injecting: cold medication from the refrigerator increases discomfort and local reaction. Remove the pen 30 minutes before injection.
• Inject slowly: once the needle is in place, depress the injection button slowly and hold it for 5-10 seconds after the click to ensure full dose delivery before withdrawing.
• Clean the skin with an alcohol swab and allow it to dry completely before injecting. Injecting through wet alcohol can sting.
• Do not inject into areas of active skin irritation, scars, tattoos, or stretch marks if possible.
• Avoid injecting near waistbands, bra straps, or elastic areas that will rub the injection site afterward.
• If you are sensitive, applying an ice cube to the site for 30-60 seconds before injection can reduce sensation and local reaction.

Abnormal Reactions: What to Watch For

Signs of Infection

Infections at subcutaneous injection sites are uncommon but possible, particularly if technique is poor or the skin was not properly cleaned. Warning signs include:

• Redness that is spreading rather than fading, extending beyond a 2 cm area 24-48 hours after injection
• Warmth at the site that worsens over time
• Increasing pain or tenderness rather than decreasing
• Pus or discharge from the injection point
• Fever or feeling generally unwell

These signs warrant prompt medical evaluation. Cellulitis (skin infection) from injection sites requires antibiotic treatment.

Lipohypertrophy

If you notice a persistent, firm, rubbery nodule under the skin at a frequently-used injection site — one that does not resolve within a few weeks — this is likely lipohypertrophy. It is painless but problematic: injecting into lipohypertrophic tissue results in erratic drug absorption. The treatment is to permanently avoid that area. Most lipohypertrophic nodules gradually soften and reduce over months once the site is rested.

Allergic Reactions

True allergic reactions to GLP-1 medications are rare but possible. A localized allergic reaction may appear as a large hive-like (urticarial) welt that is significantly bigger than a typical reaction, very itchy, and may appear or worsen over several hours.

A systemic or severe allergic reaction (anaphylaxis) is a medical emergency. Symptoms include facial or throat swelling, difficulty breathing, dizziness, rapid heart rate, or generalized hives spreading beyond the injection site. Call emergency services immediately. All injectable medications carry a small anaphylaxis risk, and patients should be aware of these warning signs.

When to Contact Your Provider

• Redness, warmth, or swelling at the injection site that is worsening rather than improving after 48 hours
• A persistent nodule that does not resolve within 3-4 weeks
• Any large hive-like reaction at the site
• Facial swelling, difficulty breathing, or other signs of systemic allergic reaction (call emergency services immediately)
• Repeated bruising at every injection despite technique correction (may suggest a clotting or medication interaction)

For the majority of GLP-1 users, injection site reactions are a minor, manageable inconvenience. Systematic rotation, good technique, and attention to the warming and drying steps eliminate most problems before they start.

Sources

• Ozempic (semaglutide) Prescribing Information. Novo Nordisk.
• Wegovy (semaglutide) Prescribing Information. Novo Nordisk.